Brenton Karl Ahrens

age:

62 years

appointments:

3 active

0 prior

primary industry:

Scientific research and development

about Brenton

Since 2018, Mr Ahrens has been a director of 3 companies, the current directorship have a combined turnover of approximately £4.7m.

Combined Valuation

£38.7m

Combined Turnover

£4.7m

active directorships over time

company
turnover
valuation
start
end
status
role
grey wolf therapeutics limited£2.8m£26.5mMar 2018-OpenDirector
pathios therapeutics limited£1.1m£7.5mAug 2019-OpenDirector
thirtyfivebio limited£805.8k£4.8mApr 2021-OpenDirector